Lymph node macrophage

“Lymphatic tissue macrophages” refers to macrophage populations residing in lymph nodes, not a single molecule or receptor; thus it is not a discrete drug target entity. Lymph node macrophages are specialized tissue-resident professional phagocytes of the mononuclear phagocyte system that line the subcapsular and medullary sinuses and medullary cords, where they capture antigens and pathogens carried by afferent lymph, clear debris, and help coordinate adaptive immune responses within the node[8]. Like other tissue macrophages, they perform phagocytosis, immune surveillance, and contribute to inflammation resolution and tissue homeostasis, with functional diversity influenced by polarization states and local cues[6][3][5]. In disease, macrophage populations contribute to host defense against infection, can participate in chronic inflammation, and in cancer contexts macrophage-directed strategies (often via CSF1/CSF1R axis or polarization modulation) are explored therapeutically, but these approaches target macrophage biology broadly rather than a specific “lymphatic tissue macrophage” receptor or enzyme[7][8].

Other names

Lymphatic tissue macrophage[8]Lymph node macrophage subsets (subcapsular sinus macrophage, medullary sinus macrophage, medullary cord macrophage)[8]Tissue-resident macrophage (lymph node)[8]Mononuclear phagocyte (lymph node)[8]

CSF1/CSF1R blockade to reduce macrophage survival/recruitment or reprogram macrophage phenotypes[8][7] Modulation of macrophage polarization (shifting M2-like immunosuppressive states toward M1-like pro-inflammatory, tumoricidal states)[7][6]